Draft:Harry Haverkos

Harry William Haverkos Harry William Haverkos (born 1951) is an American physician and epidemiologist who participated in early epidemiologic investigations of the acquired immunodeficiency syndrome (AIDS) epidemic at the Centers for Disease Control and Prevention (CDC) and later held positions at the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA). His work has focused on AIDS epidemiology, opportunistic infections, Kaposi’s sarcoma, and hypotheses regarding multifactorial disease causation.¹,² A commentary in the Journal of Biosciences described Haverkos’s account of CDC investigations as illustrative of early field epidemiology conducted during a period when the etiology of AIDS had not yet been established.² In contemporaneous reporting, The New York Times identified Haverkos as an AIDS epidemiologist and quoted him regarding possible cofactors influencing Kaposi’s sarcoma patterns among AIDS patients.¹ Early life and education Haverkos was born in Cincinnati, Ohio, in 1951.³ He received a Bachelor of Science degree from the University of Notre Dame in 1973 and an M.D. from the Medical College of Ohio at Toledo in 1976.³ He completed an internal medicine internship and residency at Akron City Hospital (1976–1979) and an infectious diseases fellowship at the University of Pittsburgh (1979–1981).³ Career Centers for Disease Control and Prevention In 1981, Haverkos joined the CDC’s Epidemic Intelligence Service and was assigned to the Kaposi’s Sarcoma and Opportunistic Infections Task Force, which investigated early cases of what became known as AIDS.³,⁴ The CDC’s early response included surveillance, case definitions, and epidemiologic investigations conducted before identification of a causative agent.⁴ Retrospective commentary has described this period as one in which case series and case–control studies were central to investigating a disease of unknown etiology.² Haverkos contributed to epidemiologic studies of AIDS among multiple populations, including men who have sex with men, people who injected drugs, and transfusion recipients.³ In a national case–control study, Jaffe, Choi, Thomas, Haverkos, and colleagues reported epidemiologic differences between AIDS patients with Kaposi’s sarcoma and those with Pneumocystis carinii pneumonia, including an association between nitrite inhalant use and Kaposi’s sarcoma.⁵ These findings were discussed in contemporaneous reporting and contributed to hypotheses under investigation during the early years of the epidemic.¹,⁵ Later reviews described nitrite inhalants as a possible cofactor considered at a time when the cause of AIDS had not yet been established.⁶ National Institutes of Health From 1984 to 1986, Haverkos served as an Opportunistic Infections Program Officer at the National Institute of Allergy and Infectious Diseases.³ During this period, he was quoted in The New York Times in relation to studies of Kaposi’s sarcoma trends and possible cofactors.¹ He later joined the National Institute on Drug Abuse, where his research addressed drug use, HIV transmission, and the health effects of nitrite inhalants.³ In 1988, Haverkos and Robert Edelman published a review in JAMA on the epidemiology of AIDS among heterosexual populations in the United States.⁷ Walter Reed Army Medical Center and FDA Haverkos served as a staff physician in the Infectious Disease Service at Walter Reed Army Medical Center, providing outpatient care for patients with HIV infection.³ From 1998 to 2006, he served as a medical officer in the Division of Antiviral Drug Products at the FDA’s Center for Drug Evaluation and Research.³ After retiring from the U.S. Public Health Service in 2006, he served as a special volunteer at the National Cancer Institute and later held an academic appointment at the Uniformed Services University of the Health Sciences.³ Research Haverkos’s research has addressed AIDS epidemiology, opportunistic infections, Kaposi’s sarcoma, and multifactorial models of disease causation.³⁶ His early work took place during a period in which multiple infectious and environmental hypotheses were under consideration.² The viral etiology of AIDS was subsequently clarified through virologic research. In 1983, Barré Sinoussi, Montagnier, and colleagues reported isolation of a retrovirus from a patient at risk for AIDS.⁸ In 1984, Gallo and colleagues reported frequent detection of related retroviruses in patients with AIDS or at risk for AIDS.⁹ Scientific understanding of Kaposi’s sarcoma later evolved substantially. In 1994, Chang, Cesarman, Moore, and colleagues reported herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma, leading to identification of Kaposi’s sarcoma–associated herpesvirus.¹⁰ Subsequent reviews describe Kaposi’s sarcoma as a vascular tumor associated with human herpesvirus 8.¹¹ Haverkos continued to publish on possible cofactors in Kaposi’s sarcoma after HIV causation was established, including a 1994 review describing nitrite inhalants as a candidate cofactor.⁶ Publications and books Haverkos is the author or co-author of peer-reviewed publications on AIDS epidemiology, opportunistic infections, Kaposi’s sarcoma, and nitrite inhalants.³ Notable publications include early CDC-associated epidemiologic studies as well as later reviews on disease causation and cofactors.5,6,7 He co-edited Health Hazards of Nitrite Inhalants, a National Institute on Drug Abuse research monograph published in 1988.³ He later authored On the Front Lines of the AIDS Pandemic and Inside the AIDS Fight: Memoir of an Epidemiologist at the Pandemic Front Lines.² Personal life Haverkos married Lynne M. Haverkos, MD, MPH, in 1977. Following her death in 2023, he established a public health scholarship in her honor at Kent State University.¹² References 1. Altman LK. Scientists are puzzled by decline of a rare cancer in AIDS victims. The New York Times. June 16, 1986. 2. Kang G. Case studies, case series and biological plausibility. Journal of Biosciences. 2013;38(5):825–827. 3. Global Health Chronicles (David J. Sencer CDC Museum). Haverkos, Harry. Accessed June 28, 2026. 4. CDC Foundation. The early years of AIDS: CDC’s response to an historic epidemic. December 1, 2017. 5. Jaffe HW, Choi K, Thomas PA, Haverkos HW, et al. National case-control study of Kaposi’s sarcoma and Pneumocystis carinii pneumonia in homosexual men: epidemiologic results. Annals of Internal Medicine. 1983;99(2):145–151. 6. Haverkos HW, Kopstein AN, Wilson H, Drotman DP. Nitrite inhalants: history, epidemiology, and possible links to AIDS. Environmental Health Perspectives. 1994;102(10):858–861. 7. Haverkos HW, Edelman R. The epidemiology of acquired immunodeficiency syndrome among heterosexuals. JAMA. 1988;260(13):1922–1929. 8. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868–871. 9. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224(4648):500–503. 10. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–1869. 11. Cesarman E, Damania B, Krown SE, et al. Kaposi sarcoma. Nature Reviews Disease Primers. 2019;5:9. 12. Tipton A. Inside the AIDS fight: Harry Haverkos, MD, shares his story at Kent State. Kent State University College of Public Health. October 1, 2025.

• Comment: This is incredibly difficult to read, as it doesn't have any paragraph breaks and the citations are not formatted in the traditional way. You may wish to see Help:Referencing for beginners. 🏳️‍🌈JohnLaurens333 (They/them • Ping me!) 02:25, 24 May 2026 (UTC)

---

Harry William Haverkos, MD (born 1951, Cincinnati, Ohio) is an American physician, epidemiologist, and author who played a significant role in the early investigation of the AIDS epidemic in the United States.[1][2][14] A retired Captain in the United States Public Health Service Commissioned Corps, Haverkos served in key positions at the Centers for Disease Control and Prevention (CDC), the National Institute on Drug Abuse (NIDA), the National Institute of Allergy and Infectious Diseases (NIAID), and the Food and Drug Administration (FDA).[8][14] He is known for his pioneering epidemiological research on AIDS co-factors, particularly the association between nitrite inhalant ("poppers") use and Kaposi's sarcoma, and for challenging the prevailing single-cause theory of AIDS as early as 1983.[3][4]

Early life and education

Haverkos earned a Bachelor of Science degree in pre-professional studies, cum laude, from the University of Notre Dame in 1973. He received his Doctor of Medicine degree from the Medical College of Ohio at Toledo (now the University of Toledo College of Medicine) in 1976. He completed an internal medicine internship and residency at Akron City Hospital in Ohio (1976–1979), where he became board-certified in internal medicine, followed by an infectious diseases fellowship at the University of Pittsburgh (1979–1981).[8][14]

He later attended the Program for Senior Managers in Government at Harvard University (1990) and a Conference for Government Managers on Issues in Science and Technology Policy at the Brookings Institution (1992).[8]

Career

Centers for Disease Control (1981–1984)

Haverkos joined the CDC's Epidemic Intelligence Service (EIS) in 1981.[14] He initiated national surveillance for Kaposi's sarcoma and opportunistic infections and participated in foundational epidemiologic studies of AIDS among homosexual men, intravenous drug users, Caribbean nationals, and blood transfusion recipients.[1][2] His encounter with one of the earliest recognized AIDS patients in December 1980 during his infectious diseases fellowship at the University of Pittsburgh drew him to the emerging epidemic.[8][14]

At CDC, Haverkos coordinated two landmark cooperative therapy studies - one assessing Pneumocystis carinii pneumonia treatment and the other evaluating toxoplasma encephalitis therapy - both published in The American Journal of Medicine.[10][11] In 1983, he was among the first researchers to propose that co-factors beyond HIV, including nitrite inhalants and cytomegalovirus, played a role in determining the specific disease manifestations of AIDS.[3][4]

National Institutes of Health (1984–1998)

From 1984 to 1986, Haverkos served as an Opportunistic Infections Program Officer at NIAID, where he developed an extramural clinical and epidemiologic research program on AIDS, including the establishment of the original NIAID/NCI AIDS Clinical Trials Program.[8]

He then moved to the National Institute on Drug Abuse (NIDA) in 1986, where he developed an extramural program on AIDS and drug abuse treatment. At NIDA, he served as Acting Director of the Division of Clinical Research (1989–1994) and as the Institute's AIDS Coordinator (1989–1996). From 1996 to 1998, he worked as an intramural physician-scientist in the Clinical Research Unit of NIDA's Addiction Research Center in Baltimore.[8]

Food and Drug Administration (1998–2006)

From 1998 to 2006, Haverkos served as a Medical Officer in the Division of Antiviral Drug Products at the FDA's Center for Drug Evaluation and Research (CDER), reviewing clinical aspects of drug development to treat HIV, herpesviruses, and other viral infections.[8]

Walter Reed Army Medical Center (1989–2006)

Concurrently, Haverkos served as a Staff Physician in the Infectious Disease Service at Walter Reed Army Medical Center, providing outpatient medical care for HIV-infected patients.[8]

Post-retirement

After retiring from the US Public Health Service in 2006, Haverkos served as a Special Volunteer at the National Cancer Institute's Division of Cancer Epidemiology and Genetics (2006–2009) and as Associate Professor of Preventive Medicine and Biometrics at the Uniformed Services University of the Health Sciences (USU), where he taught courses in Classic Studies in Epidemiology and Field Epidemiology from 2007 to 2016.[8]

Research

AIDS co-factors and Kaposi's sarcoma

Haverkos is widely recognized for his research into co-factors in AIDS, particularly the epidemiological association between nitrite inhalant ("poppers") abuse and the development of Kaposi's sarcoma among AIDS patients.[3][6] His 1985 paper in Sexually Transmitted Diseases, "Disease Manifestation among Homosexual Men with Acquired Immunodeficiency Syndrome: A possible role of nitrites in Kaposi's sarcoma," was among the first to propose a multifactorial model of AIDS-related disease. This work suggested a two-step process in which HIV causes immunodeficiency while specific co-factors trigger particular opportunistic diseases.[3][4]

He continued this line of research throughout his career, publishing extensively on the topic in journals including the Journal of Acquired Immune Deficiency Syndromes, Biomedicine and Pharmacotherapy, Environmental Health Perspectives, and the Journal of Biosciences.[12]

Multifactorial disease etiology

Beyond AIDS, Haverkos applied the multifactorial co-factor model to other diseases. He published research proposing multifactorial etiologies for cervical cancer (involving human papillomavirus and chemical co-carcinogens such as coal tar derivatives), Type 1 diabetes mellitus (involving enteroviruses and other factors), and Kaposi's sarcoma (involving HHV-8, immunosuppression, and vasoactive agents).[9][12] His 2004 review "Viruses, Chemicals and Co-carcinogenesis" in Oncogene synthesized this body of work.[9]

Schizophrenia meta-analysis

In recent years, Haverkos has been conducting a meta-analysis investigating the multifactorial causes of schizophrenia, building on a 2014 paper co-authored with J. Millegan in Research.[13]

Selected publications

Haverkos is the author or co-author of more than 100 peer-reviewed journal articles, book chapters, and scientific abstracts. Notable publications include:

• "Epidemiologic aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections." New England Journal of Medicine (1982) - as part of the CDC Task Force [1]
• "National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men." Annals of Internal Medicine (1983) [2]
• "Disease Manifestation among Homosexual Men with AIDS: A possible role of nitrites in Kaposi's sarcoma." Sexually Transmitted Diseases (1985) [3]
• "Factors associated with the pathogenesis of AIDS." Journal of Infectious Diseases (1987) [4]
• "The epidemiology of AIDS among heterosexuals." JAMA (1988) [5]
• "Viruses, Chemicals and Co-carcinogenesis." Oncogene (2004) [9]

Books

Health Hazards of Nitrite Inhalants (1988) [6]

• Haverkos HW, Dougherty JA (editors). Health Hazards of Nitrite Inhalants. National Institute on Drug Abuse Research Monograph 83. U.S. Government Printing Office, Washington, DC. DHHS publication number (ADM) 89-1573. 105 pages.
• This NIDA Research Monograph, co-edited with John A. Dougherty, compiled scientific research on the health risks associated with nitrite inhalant abuse, including their role as a potential co-factor in the development of Kaposi's sarcoma among AIDS patients.
• On the Front Lines of the AIDS Pandemic (2012) [7]
• Haverkos, HW. On the Front Lines of the AIDS Pandemic. LAP Lambert Academic Publishing, Saarbrucken, Germany. ISBN 978-3-659-12401-3. 87 pages.
• This volume chronicles Haverkos's experiences as a frontline epidemiologist during the AIDS crisis, drawing on his work at the CDC, NIH, and other federal health agencies.
• Inside the AIDS Fight: Memoir of an Epidemiologist at the Pandemic Front Lines (2025) [8]
• Haverkos, HW. Inside the AIDS Fight: Memoir of an Epidemiologist at the Pandemic Front Lines. McFarland and Company. ISBN 978-1-4766-9614-0.
• This memoir provides a comprehensive account of Haverkos's career investigating the AIDS epidemic, from his first encounter with an AIDS patient in 1980 through decades of research and public health service. The book discusses his work at the CDC, NIH, NIDA, and FDA, and presents his case for the role of co-factors in AIDS-related diseases.

Honors and awards

• Public Health Service Unit Commendation for developing AIDS surveillance (1984) [8]
• CDC Statistical Award for "Estimating the Mean Incubation Period of Transfusion-Associated AIDS" (1987) [8]
• PHS Commendation Medal for leadership in AIDS and Injecting Drug Use research (1988) [8]
• PHS Outstanding Service Medal for leadership of clinical and AIDS research programs at NIDA (1991) [8]
• Katharine Rosenbaum Boucot Sturgis Visiting Professor, Medical College of Pennsylvania and Hahnemann University (1996) [8]
• PHS Crisis Response Service Award for response to Hurricane Katrina (2006) [8]

Personal life

Haverkos was born in Cincinnati, Ohio in 1951. He married Lynne M. Haverkos, MD, MPH, in 1977. Lynne was a physician at the National Institute of Child Health and Human Development (NICHD). She passed away in 2023. They have three children and eight grandchildren. Haverkos resides in Rockville, Maryland.[8]

References

• [1] CDC Task Force on Kaposi's Sarcoma and Opportunistic Infections. "Epidemiologic aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections." New England Journal of Medicine 306 (1982): 248-52.
• [2] Jaffe HW, Choi K, Thomas PA, Haverkos HW, et al. "National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Epidemiologic results." Annals of Internal Medicine 99 (1983): 145-51.
• [3] Haverkos HW, Pinsky PF, Drotman DP, Bregman DJ. "Disease manifestation among homosexual men with acquired immunodeficiency syndrome: A possible role of nitrites in Kaposi's sarcoma." Sexually Transmitted Diseases 12 (1985): 203-208.
• [4] Haverkos HW. "Factors associated with the pathogenesis of AIDS." Journal of Infectious Diseases 156 (1987): 251-257.
• [5] Haverkos HW, Edelman R. "The epidemiology of AIDS among heterosexuals." JAMA 260 (1988): 1922-29.
• [6] Haverkos HW, Dougherty JA (editors). Health Hazards of Nitrite Inhalants. NIDA Research Monograph 83. U.S. Government Printing Office, Washington, DC, 1988.
• [7] Haverkos HW. On the Front Lines of the AIDS Pandemic. LAP Lambert Academic Publishing, Saarbrucken, Germany, 2012. ISBN 978-3-659-12401-3.
• [8] Haverkos HW. Inside the AIDS Fight: Memoir of an Epidemiologist at the Pandemic Front Lines. McFarland and Company, 2025. ISBN 978-1-4766-9614-0.
• [9] Haverkos HW. "Viruses, chemicals and co-carcinogenesis." Oncogene 23 (2004): 6492-99.
• [10] PCP Therapy Project Group (Coordinator: Haverkos HW). "Assessment of Pneumocystis carinii pneumonia (PCP) therapy." American Journal of Medicine 76 (1984): 501-8.
• [11] TE Study Group (Coordinator: Haverkos HW). "Assessment of therapy for toxoplasma encephalitis." American Journal of Medicine 82 (1987): 907-914.
• [12] Haverkos HW. "Multifactorial etiology of Kaposi's sarcoma: a hypothesis." Journal of Biosciences 33 (2008): 643-651.
• [13] Millegan J, Haverkos HW. "What causes schizophrenia?" Research 1 (2014): 1172.
• [14] Haverkos HW, interviewed by Dr. Bess Miller. "CDC's Early Response to AIDS." The Global Health Chronicles, April 26, 2017.

External links

• Global Health Chronicles Oral History Interview (2017)
• Inside the AIDS Fight - McFarland Books
• Inside the AIDS Fight on Amazon